Current Trends in Clinical Trials of Prodrugs
The development of new drugs is a lengthy and complex process regarding its conception and ideation, passing through in silico studies, synthesis, in vivo studies, clinical trials, approval, and commercialization, with an exceptionally low success rate. The lack of efficacy, safety, and suboptimal p...
Saved in:
| Main Authors: | Diogo Boreski, Valentine Fabienne Schmid, Priscila Longhin Bosquesi, Jean Leandro dos Santos, Cauê Benito Scarim, Viktor Reshetnikov, Chung Man Chin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/2/210 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
by: Jinzhe Liang, et al.
Published: (2024-09-01) -
Preparation of Glutathione-Responsive Paclitaxel Prodrug Based on Endogenous Molecule of L-Glutathione Oxidized for Cancer Therapy
by: Xiao Duan, et al.
Published: (2024-09-01) -
Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01) -
ENHANCE THE AQUEOUS SOLUBILITY OF DICLOFENAC THROUGH THE SYNTHESIS OF DICLOFENAC-INOSITOL PRODRUG
by: Hemn Latif Qader, et al.
Published: (2024-11-01) -
Dimensionless parameter predicts bacterial prodrug success
by: Brandon Alexander Holt, et al.
Published: (2022-01-01)